No profile data available.
Integrated BioPharma, Inc. (INBP) is a healthcare company in the additional production service providers industry, based in Hillside, United States, with about 134 full-time employees.
It reported revenue of $54.35 million for fiscal year 2025, up 8.0% from fiscal year 2024, and net income of $808,000. In Q1 2026 (the quarter ended September 30, 2025) revenue was $12.69 million, down 6.8% from a year before. Its largest business segment, Contract Manufacturing, brought in 95% of segment revenue in fiscal year 2025; United States was the largest region with 80%. Its market capitalization was $5.90 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2025; market data as of October 9, 2026.
, together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines.
Integrated BioPharma reported $54.35 million in revenue for fiscal year 2025, up 8.0% from $50.32 million in fiscal year 2024. In Q1 2026 revenue was $12.69 million.
Contract Manufacturing, with $51.68 million or 95% of segment revenue in fiscal year 2025. Next: Other Nutraceutical Businesses (5%).
United States: 80% of revenue by region in fiscal year 2025, followed by International (20%).
$5.90 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional production service providers) include DSwiss, Inc. (DQWS), Bio Essence Corporation (BIOE), Natural Alternatives International, Inc. (NAII).